Precision Proteomics is a pre-clinical stage biotechnology company commercializing a novel platform for the development of next-generation precision medicines. Precision’s technology can systematically and quantitatively profile activations of key signal pathways that drive pathogenesis and the development of resistance to therapy.
Aufero Medical Technologies have developed a device for the treatment of cardiac arrhythmia. The device will maintain contact force at a specified level during the procedure, reducing arrhythmia recurrence and repeat surgery.
Data Infusion Intelligence Inc. (DAIN²) is a platform created by the Faculty of Engineering at Western University. The platform aids businesses in visualizing, monitoring, understanding, and controlling their processes.
CellAdore Skin Health Inc.’s mission is to develop, manufacture and distribute premium products to consumers to enhance and maintain their skin health. Their vision is to be the trusted brand for skin health products developed based on rigorous scientific evidence.